July 16, 2025

New Guidelines Target Preventive Gaps in Inflammatory Bowel Disease

New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.

Conexiant

July 14, 2025

Skin Autoimmune Disorders Tied to Longer Cancer Survival

A large nationwide study in Taiwan found that patients with autoimmune skin diseases had lower all-cause and cancer-specific mortality following cancer treatment compared with those without these conditions.

Conexiant

July 14, 2025

Self-Injection Device Effective for Acne Lesions

A new multicenter trial found that self-injected low-dose triamcinolone using an assistance device was as effective and safe as physician-administered injections for inflammatory acne, with improved outcomes at higher doses for severe lesions.

Conexiant

July 10, 2025

1 in 4 U.S. Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 08, 2025

EVOO, Petrolatum Both Improve Skin Barrier Metrics

A clinical trial in healthy adults found that both extra virgin olive oil and petrolatum significantly improved skin hydration and barrier function, with differing effects on water loss and skin cell turnover.

Conexiant

July 03, 2025

Sonelokimab, Biologics Show Benefit in Hidradenitis Suppurativa

A systematic review and network meta-analysis of clinical trials found that several biologic and small-molecule therapies provided short-term improvement in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

July 02, 2025

Gel Offers Relief for Axillary Sweating 

A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.

Conexiant